Jeffrey M. Leiden, Executive Chairman at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,883 shares at $349.00 ($1.0M) on 2023-05-08, disclosed to the SEC on 2023-05-09.
Scheduled sale ($1.0M) by Executive Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $349.38 | 708 | $247K | 24.6% |
| 2 | $349.38 | 708 | $247K | 24.6% |
| 3 | $350.30 | 171 | $60K | 5.9% |
| 4 | $350.30 | 171 | $60K | 5.9% |
| 5 | $349.00 | 1,125 | $393K | 39.0% |
| Total | $349.34 avg | 2,883 |
| $1.0M |
| 100% |
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |